Patents by Inventor Thomas Luther
Thomas Luther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170110761Abstract: An ion transporting solvent for use with batteries can be improved by simultaneously shortening a phosphazene compound's pendent groups, eliminating most or all of the distal ion carriers, and randomizing the solvent molecules so as to intentionally disrupt symmetry to the maximum degree possible. The combination of these strategies dramatically improves battery performance to the point where the performance recorded is comparable to batteries using conventional organic solvents.Type: ApplicationFiled: December 27, 2016Publication date: April 20, 2017Applicant: PRINCESS ENERGY SYSTEMS, INC.Inventors: John L. Burba, III, Mason K. Harrup, Thomas A. Luther
-
Publication number: 20160294013Abstract: An ion transporting solvent for use with batteries can be improved by simultaneously shortening a phosphazene compound's pendent groups, eliminating most or all of the distal ion carriers, and randomizing the solvent molecules so as to intentionally disrupt symmetry to the maximum degree possible. The combination of these strategies dramatically improves battery performance to the point where the performance recorded is comparable to batteries using conventional organic solvents.Type: ApplicationFiled: June 7, 2016Publication date: October 6, 2016Applicant: PRINCESS ENERGY SYSTEMS, INC.Inventors: John L. Burba, III, Mason K. Harrup, Thomas A. Luther
-
Publication number: 20160285132Abstract: An ion transporting solvent for use with batteries can be improved by simultaneously shortening a phosphazene compound's pendent groups, eliminating most or all of the distal ion carriers, and randomizing the solvent molecules so as to intentionally disrupt symmetry to the maximum degree possible. The combination of these strategies dramatically improves battery performance to the point where the performance recorded is comparable to batteries using conventional organic solvents.Type: ApplicationFiled: June 7, 2016Publication date: September 29, 2016Applicant: PRINCESS ENERGY SYSTEMS, INC.Inventors: John L. Burba, III, Mason K. Harrup, Thomas A. Luther
-
Patent number: 8461321Abstract: This invention relates to the production of specific antibodies for the detection of human tumor associated urokinase-type plasminogen activator receptor (uPAR) deletion variants in biological samples as well as to their diagnostic and therapeutic application.Type: GrantFiled: June 30, 2008Date of Patent: June 11, 2013Assignee: Wilex AGInventors: Thomas Luther, Viktor Magdolen, Manfred Schmitt, Bernd Muehlenweg, Matthias Kotzsch
-
Publication number: 20120088162Abstract: An ion transporting solvent for use with batteries can be improved by simultaneously shortening a phosphazene compound's pendent groups, eliminating most or all of the distal ion carriers, and randomizing the solvent molecules so as to intentionally disrupt symmetry to the maximum degree possible. The combination of these strategies dramatically improves battery performance to the point where the performance recorded is comparable to batteries using conventional organic solvents.Type: ApplicationFiled: May 13, 2011Publication date: April 12, 2012Inventors: Mason K. Harrup, Thomas A. Luther, John Leslie Burba
-
Patent number: 8129498Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.Type: GrantFiled: November 1, 2007Date of Patent: March 6, 2012Assignee: Battelle Energy Alliance, LLCInventors: John R. Klaehn, Eric S. Peterson, Christopher J. Orme, Michael G. Jones, Alan K. Wertsching, Thomas A. Luther, Tammy L. Trowbridge
-
Patent number: 8063174Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.Type: GrantFiled: November 1, 2007Date of Patent: November 22, 2011Assignee: Battelle Energy Alliance, LLCInventors: John R. Klaehn, Eric S. Peterson, Christopher J. Orme, Michael G. Jones, Alan K. Wertsching, Thomas A. Luther, Tammy L. Trowbridge
-
Publication number: 20110263813Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.Type: ApplicationFiled: November 1, 2007Publication date: October 27, 2011Inventors: John R. Klaehn, Eric S. Peterson, Christopher J. Orme, Michael G. Jones, Alan K. Wertsching, Thomas A. Luther, Tammy L. Trowbridge
-
Publication number: 20110263727Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.Type: ApplicationFiled: November 1, 2007Publication date: October 27, 2011Inventors: John R. Klaehn, Eric S. Peterson, Christopher J. Orme, Michael G. Jones, Alan K. Wertsching, Thomas A. Luther, Tammy L. Trowbridge
-
Patent number: 7772361Abstract: A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2—, where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least five equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about fifteen equivalents.Type: GrantFiled: July 3, 2007Date of Patent: August 10, 2010Assignee: Battelle Energy Alliance, LLCInventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
-
Patent number: 7632898Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety may be included in a separatory medium. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2— where R is selected from among methyl, phenyl, vinyl, and allyl. The separatory medium may exhibit an H2, Ar, N2, O2, CH3, or CO2 gas permeability greater than the gas permeability of a comparable separatory medium comprising the PBI compound without substitution. The separatory medium may further include an electronically conductive medium and/or an ionically conductive medium. The separatory medium may be used as a membrane (semi-permeable, permeable, and non-permeable), a barrier, an ion exchange media, a filter, a gas chromatography coating (such as stationary phase coating in affinity chromatography), etc.Type: GrantFiled: July 3, 2007Date of Patent: December 15, 2009Assignee: Battelle Energy Alliance, LLCInventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
-
Publication number: 20090202504Abstract: This invention relates to the production of specific antibodies for the detection of human tumor associated urokinase-type plasminogen activator receptor (uPAR) deletion variants in biological samples as well as to their diagnostic and therapeutic application.Type: ApplicationFiled: June 30, 2008Publication date: August 13, 2009Applicant: WILEX AGInventors: Thomas LUTHER, Viktor Magdolen, Manfred Schmitt, Bernd Muhlenweg, Matthias Kotzsch
-
Patent number: 7574113Abstract: Video data and audio data of multiplexed data are separated. Abstract video data is generated from the separated video data and abstract audio data is generated from the separated audio data. Then, the abstract video data and the abstract audio data are packed and a packed video and audio data management table is generated from packed video and audio data D2 and video and audio data synchronization information D3. The packed video and audio data management table comprehensively manages the packed video and audio data. Thus, data of various video formats, various audio formats and various multiplexing formats can be monistically managed.Type: GrantFiled: April 7, 2003Date of Patent: August 11, 2009Assignees: Sony Corporation, Sony Electronics Inc.Inventors: Daizoh Nagahara, Thomas Luther, Hiroaki Eto, Kanchan Ranade, David Wang, Tetsuya Yamamoto
-
Publication number: 20090012190Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2— where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least 5 equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about 15.Type: ApplicationFiled: July 3, 2007Publication date: January 8, 2009Inventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
-
Publication number: 20090012253Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2— where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least 5 equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about 15.Type: ApplicationFiled: July 3, 2007Publication date: January 8, 2009Inventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
-
Publication number: 20080188932Abstract: Embodiments include polymeric coatings formed from poly((perfluoro)organo)phosphazene-based materials. The coatings may be utilized to coat any suitable substrates, and in some embodiments may be utilized to coat surfaces of medical implants. The poly((perfluoro)organo)phosphazene-based materials may contain some fluorine-containing groups, and some crosslinkable moieties. The poly((perfluoro)organo)phosphazene-based materials may also contain some groups suitable for covalent bonding with surfaces of particular substrates. For instance, the poly((perfluoro)organo)phosphazene-based materials may include amine-containing groups for covalently bonding to urethane surfaces.Type: ApplicationFiled: February 7, 2007Publication date: August 7, 2008Inventors: Mason K. Harrup, Frederick F. Stewart, Thomas A. Luther
-
Patent number: 7407751Abstract: This invention relates to the production of specific antibodies for the detection of human tumor associated urokinase-type plasminogen activator receptor (uPAR) deletion variants in biological samples as well as to their diagnostic and therapeutic application.Type: GrantFiled: October 6, 2003Date of Patent: August 5, 2008Assignee: Wilex AGInventors: Thomas Luther, Viktor Magdolen, Manfred Schmitt, Matthias Kotzsch
-
Patent number: 7399468Abstract: The invention concerns a method and a reagent kit for detecting cells in a biological sample using a double-fluorescence technique and the diagnostic and therapeutic application of amino acid sequence-specific antibodies against the urokinase receptor having a high affinity for tumour cell-expressed receptors.Type: GrantFiled: October 26, 2006Date of Patent: July 15, 2008Assignee: Wilex AGInventors: Thomas Luther, Martin Mueller, Sybille Albrecht, Viktor Magdolen, Olaf Wilhelm, Manfred Schmitt, Nadja Harbeck
-
Publication number: 20080096056Abstract: An ion transporting solvent maintains very low vapor pressure, contains flame retarding elements, and is nontoxic. The solvent in combination with common battery electrolyte salts can be used to replace the current carbonate electrolyte solution, creating a safer battery. It can also be used in combination with polymer gels or solid polymer electrolytes to produce polymer batteries with enhanced conductivity characteristics. The solvents may comprise a class of cyclic and acyclic low molecular weight phosphazenes compounds, comprising repeating phosphorus and nitrogen units forming a core backbone and ion-carrying pendent groups bound to the phosphorus. In preferred embodiments, the cyclic phosphazene comprises at least 3 phosphorus and nitrogen units, and the pendent groups are polyethers, polythioethers, polyether/polythioethers or any combination thereof, and/or other groups preferably comprising other atoms from Group 6B of the periodic table of elements.Type: ApplicationFiled: August 30, 2007Publication date: April 24, 2008Inventors: Mason Harrup, Joseph Delmastro, Frederick Stewart, Thomas Luther
-
Patent number: 7309758Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.Type: GrantFiled: October 19, 2004Date of Patent: December 18, 2007Assignee: Battelle Energy Alliance, LLCInventors: John R. Klaehn, Eric S. Peterson, Christopher J. Orme, Michael G. Jones, Alan K. Wertsching, Thomas A. Luther, Tammy L. Trowbridge